Live Chat ×
Skip to main content

Navigating the Challenges in an Era of Opioid Deprescribing: Behavioral Strategies for Patient Engagement and Success

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Beth D. Darnall, PhD

    Dr. Darnall is Associate Professor at Stanford University School of Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine. She is affiliated faculty of the Stanford Wu Tsai Neurosciences Institute and is faculty (by courtesy) in Psychiatry and Behavioral Sciences. She is Chief Science Officer at AppliedVR, a digital health therapeutics company. Dr. Darnall is a pain scientist and principal investigator for NIH and PCORI-funded clinical trials that broadly investigate the benefit of behavioral medicine and self-management strategies to manage acute and chronic pain and reduce need for prescription opioids.

  • Aram Mardian, MD

    Dr. Mardian is clinical associate professor of Family, Community, and Preventive Medicine at the University of Arizona College of Medicine – Phoenix, is a board-certified family physician, and holds additional certifications in addiction medicine, pain medicine, and medical acupuncture. He is the founding Chief of the Chronic Pain Wellness Center at the Phoenix VA Health Care System, which has developed into a model for interprofessional whole person care for patients with pain and opioid use disorder. Dr. Mardian was a contributor for the Arizona Opioid Prescribing Guidelines published in 2014 and 2018 and a workgroup member for the VA/DoD Clinical Practice Guideline “Management of Opioid Therapy for Chronic Pain” published in February 2017. He serves as Co-Chair for the Health Care Advisory Team for the Arizona Prescription Drug Misuse & Abuse Initiative and Co-Chair for the Arizona Pain and Addiction Curriculum Workgroup.

July 12, 2019
Fri 2:00 PM CDT

Duration 1H 0M

This live web event has ended.